Research Paper Volume 15, Issue 11 pp 4963—4985
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
Figure 4. Function and pathway enrichment analysis. (A) GO enrichment analysis. (B) GSVA analysis in high- and low-FDX1 expression groups.